Fig. 2.

Experimental estimation of the properties of 14 compounds, for which high binding energy for the 3D structure of DLX5 was predicted: their efficacy was estimated by the impact on proliferation of Dlx5 positive mouse lymphoma cells 42-936 (A) and cytotoxicity measured by the impact on proliferation of normal human ovarian epithelial cells (B). K - is the level of proliferation in the control. The columns depicting the effect of the most promising compounds are labeled with asterisks (Q12(*) and Q9(**)).